Ectoderm cells in animal caps from Xenopus embryos develop to form either epidermis or neural tissue depending upon their receipt of intercellular signals. To date, several secreted neural inducers have been identified which act through the local inhibition of bone morphogenetic protein (BMP) signaling, preventing differentiation to epidermis and resulting in adoption of neural fate. In this work, we have exploited an interspecies animal cap assay, which enables detection of the effects of signaling molecules produced by cells of one animal cap and influencing development in a second cap cultured in close apposition in a Holtfreter combination. We show that expression of the T-box protein, Xbra3, in one cap causes the production of a factor, which causes adoption of neural fate by cells of the other animal cap. The action of this factor is not inhibited by the over-expression of BMP in cells of the responding animal cap, or by the inhibition of Wnt signaling. These findings suggest the existence of a secreted signaling molecule that is able to induce ectodermal cells to adopt neural fate by a mechanism independent of the inhibition of the BMP or Wnt signaling pathways. q
Introduction
In vertebrate embryos, the central nervous system arises from cells of the ectoderm which are instructed early in gastrulation to adopt a neural fate. Pioneering experiments by Hans Spemann and Hilde Mangold (Spemann and Mangold, 1924) showed that in amphibian embryos, transplantation of tissue of the dorsal blastopore lip to ventral regions of other embryos resulted in the development of an entire embryonic axis, including nervous tissue, from cells of the host embryo. This experiment demonstrated the existence of intercellular signals, emanating from dorsal lip tissue, and able to act on cells to cause development of nervous tissue. This observation has since been extended to embryos of other chordates, including birds (Storey et al., 1992) and mammals (Beddington, 1994) .
The nature of the molecules which mediate signaling in neural induction has been a subject of intense investigation since the properties of the organiser were first described. Experiments in which disaggregated Xenopus ectodermal cells were shown to express markers of neural determination (Godsave and Slack, 1989; , first suggested the hypothesis that neural development may be a default fate for ectoderm (Hemmati-Brivanlou and Melton, 1997b ). Subsequently, it was shown that active signaling by bone morphogenetic proteins (BMPs) is required for development of epidermis and that one role of the organiser is to produce secreted molecules which locally inhibit BMP function, preventing development of ectoderm to epidermis and permitting adoption of a neural fate. These secreted factors include noggin, chordin, follistatin and cerberus (Hemmati-Brivanlou et al., 1994; Lamb et al., 1993; Sasai et al., 1994; Piccolo et al., 1999) , which act by binding directly to BMP molecules, thereby preventing their interaction with receptors. Wnt signaling can also lead to neuralisation of the ectoderm, but this route also relies on inhibition of BMP activity, through transcriptional repression of the BMP4 gene (Baker et al., 1999) . This view of neural induction by secreted organiser molecules has been reinforced through comparisons with the situation in Drosophila. Here, the BMP4 homologue Decapentaplegic, which induces dorsal cell fates in Drosophila ectoderm, is inhibited ventrally by the chordin homologue, short gastrulation, leading to neural development (Holley et al., 1995) . This similarity of pathways leading to neural development in protostome and deuterostome animals led to speculation that formation of neural tissue as a default response to inhi-bition of BMP4 signaling may represent an ancient, conserved developmental pathway throughout bilateral animals (De-Robertis and Sasai, 1996) .
In both mice and zebrafish, where mutations inactivating genes coding for potential neural inducers can be recovered, there is evidence that mutation of these BMP inhibitors is insufficient to prevent neural tissue from forming. Thus, in mice, both single and double mutants in chordin and noggin result in embryos which still produce neural tissue, though neural patterning is severely affected (Bachiller et al., 2000) . In fish, mutations in the chordin homologue chordino also allow the production of neural tissue, though the neural plate is of reduced size, as is the dorsal mesoderm (SchulteMerker et al., 1997) . As the organiser is the source of several BMP antagonists, neither of these observations alone is particularly convincing. However, genetic ablation of the organiser in mice, through targeted mutation of HNF3b (Klingensmith et al., 1999) or in fish, through mutations in nodal relatives cyclops and squint (Feldman et al., 1998) , or their signal transducer one eyed pinhead (Gritsman et al., 1999) , produces embryos in which at least some neural tissue forms. This leads to the suggestion that the organiser and its axial mesoderm derivatives are not the only source of neural inducing signals.
The same conclusion has been reached on the basis of earlier experiments mapping the location of neural inducing signals in Xenopus embryos (Jones and Woodland, 1989) . This has led to the question of whether BMP antagonists originating from the organiser are in themselves sufficient for induction of the nervous system during normal development (Harland, 2000) . This question has also been addressed in chick, where implantation of cells expressing chordin or noggin are unable to mimic the effect of transplanted node cells in induction of nervous system (Streit et al., 1998; Streit and Stern, 1999b) . In addition, our own more recent results in Xenopus, examining the mechanism by which Xbra3 is able to induce neural tissue in animal cap cells (Strong et al., 2000) , suggests that induction can occur by a mechanism independent of BMP inhibition. Xbra3 was originally isolated on the basis of its similarity to Xbra, the Xenopus homologue of the mouse Brachyury gene. Brachyury is known, from the phenotype of mutant mice, to be required for normal axial development and, although neural defects are seen in Brachyury mutant embryos (Chesley, 1935; Gluecksohn-Schoenheimer, 1938) , it was assumed that effects on the nervous system were a consequence of the role played by Brachyury in the development of the mesoderm. Xbra3, like Xbra, clearly also plays a role in mesoderm development in Xenopus. However, unlike Xbra, Xbra3 is able to elicit the production of neural tissue by a mechanism which is separable from its activity in induction of mesoderm (Strong et al., 2000) . We have shown that animal caps taken from Xenopus embryos injected with Xbra3 message produce a neuralising signal which is able to elicit the formation of neural tissue independent of mesoderm formation in adjacent, uninjected caps (see Strong et al., 2000) . In parallel experiments with Xbra injected caps, no neural induction was detected. These experiments were made possible by using Xenopus laevis and Xenopus borealis embryos as injected and uninjected donors, respectively. Identification of species-specific differences between transcripts used as markers of neural differentiation enabled the distinction to be made between neuralisation in the injected and uninjected cap.
In this work, we report experiments on the mechanism by which Xbra3 is able to induce neural tissue. We have developed an interspecies animal cap sandwich assay to demonstrate that over-expression of Xbra3 mRNA in the animal caps of one species induces neural marker gene expression in a non-cell autonomous manner in animal caps of the other. We show that this non-cell autonomous induction of neural tissue downstream of Xbra3 is independent of FGF signaling. Furthermore, we show that while overexpression of BMP4 inhibits neural induction by noggin in this system, it does not inhibit neural induction downstream of Xbra3. We also show that inhibition of the Wnt signaling pathway, by the use of a dominant negative TCF (T-cell specific transcription factor), fails to interfere with this induction of nervous system, thus confirming that Wnts acting through the canonical pathway, play no role in this induction process (Domingos et al., 2001; Molenaar et al., 1996; Wessely et al., 2001 ). This provides direct evidence that neural induction can occur by a pathway that does not involve the inhibition of BMP or Wnt proteins. Furthermore, these observations also provide a model system with which to further study and characterise the activity concerned.
Results

A strategy for the detection of signaling between animal caps
A novel experimental strategy was developed to test whether Xbra3 is capable of inducing neural tissue in a non-cell autonomous manner. This strategy made use of differences in gene sequences between two species of Xenopus, X. borealis and X. laevis. The identification of sequence differences between homologous genes in these species allows the species-specific detection of neural marker gene mRNAs by reverse-transcription-polymerase chain reaction (RT-PCR). Utilising these differences, we have developed a sandwich assay in which animal caps derived from each of the two species are co-cultured in a Holtfreter combination. Embryos from one species are microinjected with Xbra3 mRNA synthesised in vitro and during the period of incubation are able to signal to the adjoining cap ( Fig. 1 and Strong et al., 2000) . The receipt of a neural inducing signal can be identified by the species-specific detection of the expression of neural marker genes in the uninjected caps.
In order to be able to identify species-specific mRNAs, the X. borealis Hoxb9 gene was cloned and partially sequenced. RNA was isolated from whole, stage 25, X. laevis and X. borealis embryos from the laboratory Xenopus colonies, and reverse transcribed. Hoxb9 cDNAs were amplified from each species using primers designed to amplify X. laevis Hoxb9 (Table 1) but which also generated a X. borealis product of a similar size. The cDNAs were cloned into pGEM-T Easy and sequenced. Fig. 2 shows an alignment of the Hoxb9 cDNA sequences obtained from PCR-amplified sequences derived from the two species. In addition to several single and double base alterations, the two genes each contain short blocks of sequences, which do not align with the homologue from the other species. These differences allowed the design of species-specific primers to amplify products from one species in preparations containing a mixture of cDNAs from both species. The positions of the primers are shown in Fig. 2 and their sequences are shown in Table 1 . The use of these primer pairs allows the specific amplification of either X. borealis or X. laevis specific Hoxb9 sequences (Fig. 3A) .
Quantitative RT-PCR relies on equalisation of input cDNA between samples, usually through the amplification of a control transcript, the abundance of which is believed not to vary, or which varies following a very precise developmental profile. In experiments involving only X. laevis caps EF1a transcripts are normally amplified using gene specific primers designed to amplify the X. laevis cDNA. Although these primers amplified EF1a cDNA from both species, the X. borealis cDNA was amplified less efficiently, presumably due to sequence heterogeneity between the two species in the regions chosen for primer design. This difference in amplification meant that the PCR reaction could not be equalised by comparing amplification of EF1a cDNA. Thus, in experiments utilising cDNAs extracted from both species, samples were equalised by a different method, utilising the incorporation of trace amounts of 32 P-labelled dGTP into the cDNA reactions as described in Section 4. Equal amounts of total cDNA were then introduced into the PCR reaction. The efficacy of this method was illustrated by comparing EF1a amplification with 32 P-labelled dGTP incorporation for multiple cDNA samples (data not shown).
2.2. Xbra3 can elicit the formation of neural tissue in a noncell-autonomous manner in either X. laevis or X. borealis.
We have previously shown that when X. laevis is injected Fig. 2 . Alignment of partial Hoxb9 cDNA sequences from Xenopus borealis (xbhoxb9) and Xenopus laevis (xlhoxb9, GenBank M17447). Positions of primers used to specifically amplify Hoxb9 transcripts from each species are indicated. Fig. 1 . Construction of animal cap combinations. Caps were dissected from stage 9 embryos of each species, one or both of which had been injected with in vitro synthesised RNA, and cultured either in combination or separately until control embryos had developed to the desired stage. RNA was isolated from harvested tissues and analysed by RT-PCR. Fig. 3 . Non-cell-autonomous induction of neural tissue by Xbra3 is not FGF dependent. (A) Animal caps were taken from either Xenopus borealis (Xb) or Xenopus laevis (Xl) embryos injected with Xbra3 RNA and cultured in combination with caps from uninjected embryos of the other species. In each case, Hoxb9 expression is upregulated in both caps. Hoxb9 is not upregulated by caps from Xbra injected or uninjected embryos cultured in combinations, nor in caps from uninjected embryos cultured alone. Analysis of RNA from whole embryos of each species demonstrates the specificity of the RT-PCR procedure. (B) Animal caps were taken from Xenopus laevis embryos injected with XFD RNA and cultured in the presence or absence of FGF. XFD expressing caps fail to respond to FGF as indicated by their failure to express Xbra, demonstrating the effectiveness of XFD in blocking FGF signaling. (C) XFD-expressing Xenopus laevis animal caps respond to Xbra3-expressing Xenopus borealis caps, with which they were cultured in combination, by expressing Otx2, while uninjected Xenopus laevis caps respond by expressing Hoxb9. In each case, the borealis cap responds to Xbra3 expression by expressing Hoxb9. Neither marker is expressed in combinations made from uninjected caps and XFD does not upregulate either marker in Xenopus laevis caps cultured alone.
with Xbra3 mRNA and caps removed and sandwiched together with caps from X. borealis, Hoxb9 is expressed in the uninjected X borealis cells. This provided the initial evidence indicating that neural induction via Xbra3 occurs in a non-cell-autonomous manner (Strong et al., 2000) . Here we confirm and extend those results to show that in combinations of injected and uninjected caps derived from the two Xenopus species, non-cell-autonomous neural induction occurs. This was an essential prerequisite to allow us to perform the subsequent experiments since X. laevis or X. borealis were both used as the signaling and responding partners in the sandwich assay.
When animal caps were taken from X. laevis embryos injected with Xbra3 and sandwiched to uninjected X. borealis animal caps, species-specific RT-PCR revealed that Hoxb9 from both species could be detected, indicating that signaling had occurred between the two caps in a non-cell-autonomous manner. Likewise when X. borealis animal caps were taken from embryos injected with Xbra3 and sandwiched with uninjected X. laevis animal caps, again Hoxb9 products from both species could be detected (Fig.  3A ). Sandwiches constructed with either Xbra injected X. borealis or X. laevis failed to show induction of Hoxb9 as expected, but have been shown previously to express markers of mesodermal differentiation (Strong et al., 2000) . Control, uninjected caps from either species did not express Hoxb9 and caps from injected embryos expressed the appropriate species-specific neural gene product, confirming the specificity of the RT-PCR.
Non-cell-autonomous induction of neural tissue by Xbra3 is not FGF dependent
Over-expression of either Xbra3 or Xbra has been shown to upregulate the expression of the secreted growth factor eFGF (Strong et al., 2000; Tada et al., 1997) . Furthermore, eFGF induces Xbra expression and bFGF induces Xbra3 (Isaacs et al., 1994; Strong et al., 2000) . It is therefore likely that Xbra3 is able to upregulate its own expression through the induction of eFGF. It is possible that in the experimental sandwich model that we have adopted, Xbra3 injected into the animal cap of one element of the sandwich can upregulate expression of Xbra3 in the adjacent cap via the induction of eFGF. If this were the case, the induction of neural tissue in the adjacent cap could be via eFGF which has been shown to be able to play a role in posterior neural induction (Barnett et al., 1998; Kengaku and Okamoto, 1995; Lamb and Harland, 1995) .
In order to test the possible role of FGFs in this process, the dominant negative receptor XFD was utilised to inhibit FGF signaling (Amaya et al., 1991) . X. borealis embryos were injected with mRNA transcribed in vitro from Xbra3, dissected at stage 9 and sandwiched with similarly dissected X. laevis embryos which had been injected with XFD mRNA. Thus the X. laevis animal cap was unable to respond to FGF signaling. The complete block to FGF signaling was demonstrated in animal caps dissected from XFD injected X. laevis embryos that were treated with recombinant FGF and then assayed by RT-PCR for the expression of Xbra. The results shown in Fig. 3B indicate that FGF signaling was completely blocked in these caps, since they did not respond to exogenously applied growth factor, although control uninjected caps clearly responded by the induction of Xbra, as demonstrated by RT-PCR. FGF responses were also assayed by observing convergent extension movements (not shown).
Inhibition of FGF signaling in Xbra3 injected animal caps completely converts the posterior neural tissue, identified by Hoxb9, to neural tissue of an anterior character, identified by Otx2 expression (Strong et al., 2000) . Consequently, sandwich experiments in which the responding cap was injected with XFD were analysed by RT-PCR for the presence of the anterior neural marker Otx2. Fig. 3C demonstrates FGFindependent non-cell-autonomous neural induction downstream of Xbra3 through the detection of X. laevis Otx2 transcripts in sandwiches between animal caps derived from Xbra3 injected X. borealis and XFD injected X. laevis embryos. Otx2 is not detected in the absence of XFD, although as expected the posterior neural marker Hoxb9 is expressed, showing that posterior neural induction is taking place. The primers used to detect X. laevis Hoxb9 and Otx2 were species-specific as shown by their ability to amplify sequences from X. laevis whole embryos, but not from whole embryos or Xbra3 injected caps from X. borealis. As expected, no neural markers were detected in control uninjected sandwiches or animal caps injected with XFD from X. laevis. Thus, non-cell-autonomous induction of tissues of neural character downstream of Xbra3 is not dependent on FGF signaling.
Induction of neural tissue by Xbra3 is independent of the inhibition of BMP signaling
We have shown previously that Xbra3 may be inducing neural tissue by a mechanism which does not involve the inhibition of BMP4 since Xbra3 does not act through the known inhibitors of BMP signaling, noggin, follistatin, chordin or Xnr3 (Strong et al., 2000) . Furthermore overexpression of Xbra3 in animal caps does not result in the decreased expression of BMP4 even though there is expression of neural markers (Strong et al., 2000) . We therefore decided to investigate directly whether over-expression of BMP4 was sufficient to inhibit the formation of neural tissue by Xbra3. In order to fully control this experiment, we initially established the conditions necessary for the overexpression of BMP4 to inhibit neural induction by noggin, a known antagonist of BMP4 (Zimmerman et al., 1996) .
To demonstrate BMP inhibition of non-cell-autonomous neural induction, X. borealis embryos were injected with in vitro transcribed noggin mRNA. Caps were dissected at stage 9 and sandwiched with either BMP4 injected or uninjected caps derived from X. laevis. The sandwiches were analysed by RT-PCR for Otx2 with X. laevis specific primers, which fail to amplify a product from X. borealis (Fig. 4A) . Expression of X. laevis Otx2 would indicate that neural induction had occurred via noggin signaling from the X. borealis cap to the X. laevis cap, as expected for a secreted molecule like noggin, which induces anterior neural tissue through inhibition of BMP (Zimmerman et al., 1996) . The specificity of the primers for X. laevis Otx2 is illustrated by the failure to amplify Otx2 sequences from X. borealis caps derived from embryos injected with noggin or from stage 25 whole X. borealis embryos and the ability to amplify sequences from stage 25 X. laevis embryos. Sandwiches containing a responding X. laevis cap injected with BMP4 mRNA, together with a signaling X. borealis cap injected with noggin, completely abolished the expression of the anterior neural marker Otx2 in the X. laevis cap confirming the antagonistic action of BMP4 over-expression on noggin-mediated neural induction.
If, however, the equivalent experiment was carried out with neural tissue elicited by Xbra3 over-expression, expression of BMP4 in the responding cap failed to abolish neural induction (Fig. 4B) . In this experiment, Xbra3 mRNA was injected into X. borealis embryos, and caps dissected at stage 9 were sandwiched to caps derived from X. laevis embryos which had been injected with either XFD mRNA, XFD and BMP4 mRNA, or with BMP4 mRNA alone. Co-injection with XFD, to inhibit FGF signaling, allowed the detection of Otx2 as a marker of neural differentiation in the X. laevis caps (see Fig. 3C ), while those caps not injected with XFD allowed detection of the posterior marker Hoxb9. Failure to amplify Otx2 or Hoxb9 from whole X. borealis embryos demonstrates specificity of the RT-PCR for the responding caps. Furthermore, caps from embryos injected with XFD mRNA either alone or with BMP4 mRNA fail to upregulate the expres- Fig. 4 . Neural induction by Xbra3-expressing animal caps is not inhibited by over-expression of BMP. (A) Animal caps were taken from Xenopus borealis embryos injected with noggin RNA and cultured in combination with animal caps from Xenopus laevis. Expression of Otx2 in the X. laevis cap indicated noncell-autonomous neural induction by the noggin-expressing borealis cells. The induction of Otx2 is inhibited by over-expression of BMP in the responding laevis cap and the specificity of the PCR reaction is demonstrated by analysis of whole embryos. B: Otx2 is upregulated in XFD-expressing Xenopus laevis caps cultured in combination with Xbra3-expressing caps from Xenopus borealis. Otx2 expression is not inhibited by over-expression of BMP in the laevis cap. In the absence of XFD, the Xenopus laevis cap responds by expressing Hoxb9, which is also not inhibited by expression of BMP in the laevis cap. sion of either Otx2 or XFD, as expected. Control uninjected samples also fail to express either neural marker. Injection of BMP4 mRNA fails to inhibit the induction of the Otx2 neural response to Xbra3 in sandwiches co-injected with XFD. Injection of BMP4 mRNA alone also fails to inhibit the induction of Hoxb9 by Xbra3.
Early Wnt signaling in the prospective dorsal region of the Xenopus embryo has been shown to result in both the expression of BMP inhibitors at the blastula stage (Wessely et al., 2001 ) and also the transcriptional repression of BMP expression in gastrula stage embryos (Baker et al., 1999) . Thus, one explanation for the activity of Xbra3 in non-cell autonomous neural induction would be that Xbra3 activates production of a Wnt signal which inhibits, by one of these mechanisms, BMP signaling in the responding cap, leading to expression of neural markers. In order to confirm that the neural induction observed in responding caps was not due to the effects of members of the Wnt signaling pathway, canonical Wnt signaling was inhibited by the injection of the dominant negative transcription factor, dnTCF (Domingos et al., 2001; Molenaar et al., 1996; Wessely et al., 2001) . The effectiveness of the dnTCF was assessed in a separate animal cap experiment. The ability of Xwnt8 to activate neural development, assayed by Xnr-3 expression, was effectively inhibited by the injection of dnTCF mRNA in X. laevis animal caps dissected at stage 9 and analysed at stage 10 (Fig. 5A) . In these experiments, cDNA loading was equalised on the basis of the EF1a signal by RT-PCR. In a sandwich experiment, Xbra3 mRNA was injected into X. borealis embryos, and caps dissected at stage 9 were sandwiched to caps derived from X. laevis embryos which had been injected with XFD mRNA, XFD and dnTCF mRNA or from uninjected control caps. The sandwiches were harvested at stage 25 equivalent and analysed for expression of Otx2 in the X. laevis caps. As expected, Otx2 was expressed in X. laevis animal caps derived from the sandwiches made from Xbra3 injected X. borealis and XFD injected X. laevis caps. Otx2 was also expressed in the sandwich combinations with the addition of dnTCF. As in previous experiments (Fig. 4B) , no Otx2 was observed in combinations containing uninjected X. laevis caps in which FGF signaling was not inhibited (Fig. 5B) .
These experiments show that the X. borealis:X. laevis sandwich model mimics previous approaches to the study of neural induction by demonstrating that secreted inhibitors of BMP function, such as noggin, cause induction of neural markers in a non-cell-autonomous manner. Neural induction downstream of over-expression of Xbra3 can also occur by a non-cell-autonomous mechanism, indicating that Xbra3 expressing cells secrete a neuralising factor. The action of this factor in inducing expression of markers of neural differentiation is not inhibited by levels of BMP which are sufficient to inhibit noggin-dependent neuralisation or by levels of dnTCF sufficient to inhibit neural induction by Xwnt8, suggesting that it acts by a mechanism distinct from BMP inhibition.
Discussion
We have described in this work an interspecies assay which can powerfully detect signaling between cells in artificial sandwich recombinations. This assay has the potential to be used in the analysis of a wide variety of systems in which a soluble signal is released to responding cells. It has the advantage of not requiring the injection of lineage label or single or double in situ analysis, which is not possible for low levels of transcript and for some markers. This method provides completely unambiguous species-specific identification of responding gene products and should be readily applicable to X. tropicalis combinations in addition to those described here with X. borealis. Caps were taken at stage 9 and harvested at stage 10 equivalent and subjected to RT-PCR analysis for Xnr-3 and EF1a. The presence of the dnTCF mRNA almost completely abrogates the response of the neural inducing molecule Xnr-3. (B) Animal caps were taken from X. borealis embryos injected with Xbra3 were cultured in combination with animal caps from X. laevis either injected with XFD, XFD and dnTCF or uninjected. Samples were harvested at stage 25. The induction of Otx-2 is not inhibited by the presence of dnTCF.
Xbra3 elicits the formation of neural tissue in a noncell-autonomous manner
Our experiments clearly demonstrate that over-expression of the T-box gene, Xbra3, is able to induce the expression of neural markers in responsive ectoderm. Since Xbra3 is not normally expressed within neural tissue but is abundantly expressed in the notochord of post-gastrula, neurula and tailbud stages, the expression of Xbra3 must result either directly or indirectly in the production of a secreted factor which can perform this function. Our experiments clearly show by signaling to a sandwiched animal cap of a different species, X. borealis, that this signaling event can occur over a distance crossing at least one cell diameter. Thus we have shown that this induction occurs in a noncell-autonomous manner and is conserved at least between X. laevis and X. borealis, although the extent of interspecies conservation in other vertebrates is currently unknown.
The non-autonomous induction of neural tissue by Xbra3 is independent of the FGF signaling pathway
We have previously shown (Strong et al., 2000) that Xbra3 like Xbra can upregulate the expression of the secreted growth factor eFGF which can itself act both as a modifier of anterior nervous tissue and as an inducer of nervous tissue in its own right (Barnett et al., 1998; Kengaku and Okamoto, 1995; Lamb and Harland, 1995) . The patterned state of the neural tissue activated by cells expressing Xbra3 is consistent with the posterior neural phenotype induced by FGF raising the possibility that the non-cellautonomous induction of neural tissue by Xbra3 was mediated by FGF. We chose to block FGF signaling in the responding caps with the dominant negative receptor XFD to eliminate the role of FGF in either inducing or modifying the neural tissue produced. In each experiment, we showed the block to be effective since the mesoderm inducing effects of recombinant FGF growth factor were completely abrogated following XFD injection of responding caps. In agreement with earlier observations on X. laevis caps, when the activity of FGF was completely blocked in responding caps, neuralisation of the cap still occurred but the neural tissue produced was now of a completely anterior nature. Thus, we have demonstrated that the non-cell-autonomous signal produced by the Xbra3 injected cap is not eFGF or another member of the FGF family acting through the XFD receptor, nor is it in any way dependent on a functional FGF/ FGF receptor interaction.
Neural induction by Xbra3 is not dependent on BMP4 inhibition or Wnt signaling
Previously identified neural inducers act by locally inhibiting the function of BMPs, preventing signaling via BMP receptors and resulting in adoption by ectodermal cells of a neural fate in the absence of instructive signaling causing production of epidermis. As expected, animal cap cells in the assay used here respond to the presence of the secreted BMP inhibitor, noggin, by adopting a neural fate. This response is abrogated by over expression in the responding cells of high levels of BMP4. In contrast to this, overexpression of BMP4 fails to inhibit neuralisation in response to a secreted factor produced by adjacent animal cap cells expressing Xbra3. Importantly, not only does BMP4 expression fail to abolish neuralisation caused by adjacent Xbra3 expressing animal cap cells, but also is there no discernible reduction in the levels of expression of the two neural markers. This strongly suggests that the secreted neuralising signal produced by Xbra3 expressing animal cap cells does not act by inhibiting BMP function. This contention is further supported by the fact that inhibition of Wnt-induced neural induction by the dnTCF also fails to inhibit the activation of neural development by Xbra3. Indeed, there is a marginal upregulation in the expression of Otx2 rather than a reduction in expression levels. Thus, even though the mechanism of action by which Wnts generate nervous tissue is reported to be via the inhibition of BMPs, we show independently that Xbra3 can elicit the formation of neural tissue in the absence of Wnt signaling (Baker et al., 1999) . As Xbra3 is predominantly localised in the nuclei (Strong et al., 2000) , and is closely related to other Tdomain transcription factors, the most likely explanation for our data is that Xbra3 directly or indirectly activates expression of a secreted factor which can act on animal cap cells to cause neuralisation through a mechanism distinct from inhibition of BMP activity.
The consequences for vertebrate neural induction
A large body of experimental data has accumulated, demonstrating that inhibition of BMP signaling in Xenopus animal caps leads to the adoption of a neural fate. Although well supported, this model carries the implication that adoption of neural fate is a default pathway, i.e. animal cap cells will become neural unless instructed otherwise (Godsave and Slack, 1989; Hemmati-Brivanlou and Melton, 1997a) . In species other than Xenopus it has proved difficult to obtain persuasive evidence that inhibition of BMP function is sufficient to explain all aspects of neural induction. For example, the formation of neural plate in mouse embryos lacking both chordin and noggin suggests that neural fate may be adopted even in the presence of active BMP (Bachiller et al., 2000) . Furthermore, in the mouse, embryos lacking HNF3b fail to develop a morphologically distinguishable node and thus fail to express noggin and chordin, but despite this neural tissue still forms (Klingensmith et al., 1999) . In the chick, whilst transplanted node induces ectopic neural tissues when grafted into the epiblast at primitive streak stages, cells expressing chordin and noggin are unable to do so (Streit and Stern, 1999a; Streit and Stern, 1999b) . FGFs have been implicated directly in neural induction in the chick and recently a role for FGFs in the down-regulation of BMPs has been identi-fied (Storey et al., 1998; Wilson et al., 2001 ). This suggests that at least part of the effect of FGF in neuralisation of ectoderm is mediated through the down-regulation of BMP. Wnt signaling also appears to play a role in neuralisation in the chick. Unlike Xenopus, Wnt proteins in the chick antagonise neural induction probably by interfering with the FGF signaling, thus preventing down regulation of BMPs (Wilson et al., 2001) . However, despite the identification of some downstream events in chick neuralisation involving inhibition of action of BMP proteins, neuralisation can occur in the chick without the apparent regulation of BMP (Wilson et al., 2000) . In Xenopus both neural plate and paraxial mesoderm can neuralise competent ectoderm (Jones and Woodland, 1989; Servetnick and Grainger, 1991) , although these tissues do not appear to express BMP antagonists. In addition, zebrafish embryos lacking both BMP antagonists and functional Wnt signaling still produce neural tissue (Sirotkin et al., 2000) . Thus, the possibility exists that additional signals are present in the dorsal mesoderm, which are able to induce neural fate in the absence of BMP inhibition. Our data suggest that in Xenopus, expression of Xbra3 in the dorsal mesoderm leads to the production of a neuralising factor which acts on ectoderm cells to induce neural fate by a mechanism independent of BMP inhibition, and Wnt signalling. Xbra3 mRNA is present in the embryo both at the right time and in the right place. It is expressed during the early stages of gastrulation at high levels in the notochord throughout neurulation, past the time when Xbra can be detected in this tissue (J.C. Smith, personal communication) . This gene is therefore, at least potentially, able to influence the natural process of neural induction in vivo as well as the demonstrated effects in vitro that we present in this communication.
Materials and methods
Cloning and sequencing
PCR products were ligated into pGEM-T using the ligase buffer and enzyme provided with the plasmid. Reactions were set up with between 1 and 3 molar excess of insert over plasmid in a volume of 10 ml and were incubated overnight at 128C. Sequencing was carried out on both strands by a combination of manual sequencing and automated sequencing using an Applied Biosystems 373A instrument.
Embryo culture and dissection
All embryos used in this study were obtained by in vitro fertilisation of hormonally stimulated X. laevis and X. borealis and staged according to published tables (Nieuwkoop and Faber, 1967) . Standard embryological procedures were as described (Jones and Woodland, 1989) . Whole control, or mRNA injected, embryos were cultured in 1/10 Barth X saline after dejellying in 2% cysteine hydrochloride pH 8. Dissected caps were taken from an approximately 608arc on the animal pole. When used in sandwich combinations, animal caps from both species were dissected at stage 9 and sandwiched together in full strength Barth X saline within 30 min of dissection. Explants were cultured in full-strength Barth X saline. Whole embryo stage controls were also cultured to allow staging of the caps. For all recombination experiments, animal caps and sandwiches were harvested at stage 25 equivalent.
Growth factor treatment
In order to assess the ability of FGF to induce the expression of Xbra in XFD injected or uninjected embryos, animal caps from stage 9 embryos were incubated in Barth X saline containing 0.1 mg/ml of bovine serum and recombinant FGF (Promega) at a concentration of 50 ng/ml. Animal caps were harvested for analysis at stage 12 equivalent.
mRNA synthesis and microinjection
RNA was synthesised from plasmid templates using SP6 or T7 polymerase. All microinjections were carried out with RNA diluted to approximately 50 mg/ml. Approximately 20 nl were injected into one blastomere of dejellied twocell embryos under 5% Ficoll in Barth X. Embryos were removed from Ficoll after an overnight incubation and transferred into Barth X for dissection.
RT-PCR analysis and primers
Each group of five animal caps or sandwiches was homogenised in 150 ml XT buffer (300 mM NaCl, 20 mM TrisHCl pH 7.5, 1 mM EDTA, 1% SDS) and digested at 378C with proteinase K. Following phenol extraction and addition of 5 mg glycogen (as carrier), samples were ethanol precipitated at 2208C. Dried pellets were resuspended in 30 ml transcription buffer containing DNase I and placental RNase inhibitor and incubated for 15 min at 378C. XT buffer (120 ml) was added and samples were digested at 378C with proteinase K. After phenol and phenol/chloroform extraction, the RNA sample was ethanol precipitated at room temperature and resuspended in 10 ml water. RNA (1 mg) was used to generate first strand cDNA using random hexamers as primers. Synthesis was carried out in the presence and absence of Superscript reverse transcriptase (Gibco) and RNA. The cDNA was then used for PCR analysis using the primers shown in Table 1 . The conditions were as follows: first, denaturation step 948C for 3 min; second, annealing step 558C for 1 min; third, extension step 728C for 1 min; and fourth back to the first step for 24 cycles, with 1 min for the 948C denaturation step. The final step was 728C for 5 min. These conditions were followed for all primers except that the annealing step was at 628C for muscle actin and 588C for Xnr3 and the total number of cycles for EF1a was 20 and for Xnr-3 was 30.
4.6. Equalisation of cDNA samples from X. borealis and X. laevis cDNA synthesis reactions were set up as described previously but with the addition of 1 mCi a 32 P-dGTP to each of the reactions. One microlitre of each cDNA sample was then precipitated by addition of 20 ml SSS DNA (1 mg/ ml) and 1 ml 10% TCA and kept on ice for 15 min. The samples were then spun for 5 min at 13 000 rpm and washed once with 10% TCA before being resuspended in 50 ml TE. The samples were then mixed with 500 ml scintillation fluid and counted using a scintillation counter. 
